15-PGDH-IN-1

Modify Date: 2024-01-11 08:31:21

15-PGDH-IN-1 Structure
15-PGDH-IN-1 structure
Common Name 15-PGDH-IN-1
CAS Number 2241676-74-2 Molecular Weight 398.46
Density N/A Boiling Point N/A
Molecular Formula C24H22N4O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 15-PGDH-IN-1


15-PGDH-IN-1 is a potent and orally active 15-PGDH inhibitior. 15-PGDH-IN-1 has inhibition activity against recombinant human 15-PGDH with an IC50 value of 3 nM. 15-PGDH-IN-1 can be used for the research of tissue repair and regeneration[1].

 Names

Name 15-PGDH-IN-1

 15-PGDH-IN-1 Biological Activity

Description 15-PGDH-IN-1 is a potent and orally active 15-PGDH inhibitior. 15-PGDH-IN-1 has inhibition activity against recombinant human 15-PGDH with an IC50 value of 3 nM. 15-PGDH-IN-1 can be used for the research of tissue repair and regeneration[1].
Related Catalog
Target

IC50: 3 nM (15-PGDH)[1]

In Vitro 15-PGDH-IN-1 (compound 49) has inhibition activity against recombinant human 15-PGDH with an IC50 value of 3 nM[1]. 15-PGDH-IN-1 (4, 20, 100, 500, 2500 nM) induces PGE2 in A549 cells at 20 nM[1].
In Vivo 15-PGDH-IN-1 (compound 49) (5, 10, 20, 40 mg/kg; IV, IP, PO) shows potent inhibition of 15-PGDH, good oral bioavailability, and protective activity in mouse models of ulcerative colitis and recovery from bone marrow transplantation[1]. Animal Model: CD1 Mice (female)[1] Dosage: 5, 10 mg/kg Administration: IV, IP, PO Result: Showed a low Cmax value when dosed orally versus IP, but the AUC was only reduced by half and had good oral bioavailability (63%). Animal Model: C57Bl/6 mice[1] Dosage: 5, 20, 40 mg/kg Administration: IP, Oral Result: Showed elevation of PGE2 levels in colon and lung inhibited 15-PGDH enzymatic activity in the colon. Animal Model: DSS model[1] Dosage: 10, 40 mg/kg Administration: IP (10 mg/kg BID) or PO (40 mg/kg BID) Result: Showed protection in the mouse DSS model of ulcerative colitis.

 Chemical & Physical Properties

Molecular Formula C24H22N4O2
Molecular Weight 398.46